![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CEP250 |
Gene summary for CEP250 |
![]() |
Gene information | Species | Human | Gene symbol | CEP250 | Gene ID | 11190 |
Gene name | centrosomal protein 250 | |
Gene Alias | C-NAP1 | |
Cytomap | 20q11.22 | |
Gene Type | protein-coding | GO ID | GO:0000226 | UniProtAcc | Q9BV73 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
11190 | CEP250 | LZE4T | Human | Esophagus | ESCC | 1.30e-10 | 2.90e-01 | 0.0811 |
11190 | CEP250 | LZE5T | Human | Esophagus | ESCC | 1.24e-02 | 5.30e-01 | 0.0514 |
11190 | CEP250 | LZE7T | Human | Esophagus | ESCC | 4.87e-08 | 3.91e-01 | 0.0667 |
11190 | CEP250 | LZE22T | Human | Esophagus | ESCC | 9.39e-03 | 2.99e-01 | 0.068 |
11190 | CEP250 | LZE24T | Human | Esophagus | ESCC | 4.37e-17 | 4.70e-01 | 0.0596 |
11190 | CEP250 | P1T-E | Human | Esophagus | ESCC | 4.52e-09 | 5.32e-01 | 0.0875 |
11190 | CEP250 | P2T-E | Human | Esophagus | ESCC | 5.42e-14 | 3.57e-01 | 0.1177 |
11190 | CEP250 | P4T-E | Human | Esophagus | ESCC | 3.60e-14 | 3.13e-01 | 0.1323 |
11190 | CEP250 | P5T-E | Human | Esophagus | ESCC | 1.58e-02 | 1.31e-01 | 0.1327 |
11190 | CEP250 | P8T-E | Human | Esophagus | ESCC | 3.93e-08 | 1.96e-01 | 0.0889 |
11190 | CEP250 | P9T-E | Human | Esophagus | ESCC | 2.28e-03 | 1.27e-01 | 0.1131 |
11190 | CEP250 | P10T-E | Human | Esophagus | ESCC | 1.59e-15 | 3.52e-01 | 0.116 |
11190 | CEP250 | P11T-E | Human | Esophagus | ESCC | 1.55e-04 | 2.99e-01 | 0.1426 |
11190 | CEP250 | P12T-E | Human | Esophagus | ESCC | 2.15e-21 | 4.39e-01 | 0.1122 |
11190 | CEP250 | P15T-E | Human | Esophagus | ESCC | 6.57e-12 | 3.32e-01 | 0.1149 |
11190 | CEP250 | P16T-E | Human | Esophagus | ESCC | 2.77e-19 | 3.57e-01 | 0.1153 |
11190 | CEP250 | P20T-E | Human | Esophagus | ESCC | 2.86e-08 | 2.71e-01 | 0.1124 |
11190 | CEP250 | P21T-E | Human | Esophagus | ESCC | 9.50e-18 | 4.15e-01 | 0.1617 |
11190 | CEP250 | P22T-E | Human | Esophagus | ESCC | 6.84e-12 | 2.86e-01 | 0.1236 |
11190 | CEP250 | P23T-E | Human | Esophagus | ESCC | 5.28e-13 | 3.02e-01 | 0.108 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:1903829111 | Esophagus | ESCC | positive regulation of cellular protein localization | 199/8552 | 276/18723 | 2.99e-19 | 3.45e-17 | 199 |
GO:000931419 | Esophagus | ESCC | response to radiation | 277/8552 | 456/18723 | 4.42e-11 | 1.43e-09 | 277 |
GO:00726985 | Esophagus | ESCC | protein localization to microtubule cytoskeleton | 43/8552 | 54/18723 | 3.28e-07 | 4.61e-06 | 43 |
GO:00443804 | Esophagus | ESCC | protein localization to cytoskeleton | 45/8552 | 58/18723 | 6.89e-07 | 8.99e-06 | 45 |
GO:00070982 | Esophagus | ESCC | centrosome cycle | 85/8552 | 130/18723 | 4.41e-06 | 4.69e-05 | 85 |
GO:00310233 | Esophagus | ESCC | microtubule organizing center organization | 92/8552 | 143/18723 | 5.04e-06 | 5.31e-05 | 92 |
GO:000941611 | Esophagus | ESCC | response to light stimulus | 183/8552 | 320/18723 | 2.03e-05 | 1.76e-04 | 183 |
GO:19055086 | Esophagus | ESCC | protein localization to microtubule organizing center | 28/8552 | 35/18723 | 3.40e-05 | 2.78e-04 | 28 |
GO:00715396 | Esophagus | ESCC | protein localization to centrosome | 26/8552 | 33/18723 | 1.06e-04 | 7.43e-04 | 26 |
GO:0010457 | Esophagus | ESCC | centriole-centriole cohesion | 12/8552 | 14/18723 | 2.51e-03 | 1.08e-02 | 12 |
GO:19055153 | Esophagus | ESCC | non-motile cilium assembly | 39/8552 | 61/18723 | 3.08e-03 | 1.28e-02 | 39 |
GO:190382922 | Liver | HCC | positive regulation of cellular protein localization | 199/7958 | 276/18723 | 1.15e-23 | 2.62e-21 | 199 |
GO:0031023 | Liver | HCC | microtubule organizing center organization | 82/7958 | 143/18723 | 2.38e-04 | 1.79e-03 | 82 |
GO:0007098 | Liver | HCC | centrosome cycle | 75/7958 | 130/18723 | 3.33e-04 | 2.34e-03 | 75 |
GO:00443802 | Liver | HCC | protein localization to cytoskeleton | 38/7958 | 58/18723 | 3.37e-04 | 2.36e-03 | 38 |
GO:007269811 | Liver | HCC | protein localization to microtubule cytoskeleton | 35/7958 | 54/18723 | 7.73e-04 | 4.65e-03 | 35 |
GO:00093146 | Liver | HCC | response to radiation | 223/7958 | 456/18723 | 3.08e-03 | 1.43e-02 | 223 |
GO:190550811 | Liver | HCC | protein localization to microtubule organizing center | 23/7958 | 35/18723 | 4.72e-03 | 2.02e-02 | 23 |
GO:007153911 | Liver | HCC | protein localization to centrosome | 21/7958 | 33/18723 | 1.16e-02 | 4.28e-02 | 21 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CEP250 | SNV | Missense_Mutation | c.722G>T | p.Arg241Leu | p.R241L | Q9BV73 | protein_coding | deleterious(0.03) | benign(0.133) | TCGA-LP-A7HU-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
CEP250 | SNV | Missense_Mutation | novel | c.4550G>T | p.Arg1517Leu | p.R1517L | Q9BV73 | protein_coding | tolerated(0.18) | benign(0.287) | TCGA-LP-A7HU-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
CEP250 | SNV | Missense_Mutation | novel | c.5860C>T | p.His1954Tyr | p.H1954Y | Q9BV73 | protein_coding | tolerated(0.09) | benign(0.201) | TCGA-MA-AA3Z-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
CEP250 | SNV | Missense_Mutation | novel | c.2452N>A | p.Glu818Lys | p.E818K | Q9BV73 | protein_coding | deleterious(0) | possibly_damaging(0.857) | TCGA-VS-A953-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
CEP250 | SNV | Missense_Mutation | novel | c.670N>G | p.Thr224Ala | p.T224A | Q9BV73 | protein_coding | deleterious(0.01) | benign(0.11) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
CEP250 | SNV | Missense_Mutation | c.1598N>T | p.Ala533Val | p.A533V | Q9BV73 | protein_coding | tolerated(0.16) | benign(0.294) | TCGA-A6-6781-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | SD | |
CEP250 | SNV | Missense_Mutation | novel | c.1220N>G | p.Gln407Arg | p.Q407R | Q9BV73 | protein_coding | deleterious(0) | probably_damaging(0.969) | TCGA-AA-3949-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
CEP250 | SNV | Missense_Mutation | rs763406705 | c.3134G>A | p.Arg1045Gln | p.R1045Q | Q9BV73 | protein_coding | tolerated(0.17) | benign(0.005) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
CEP250 | SNV | Missense_Mutation | rs781762969 | c.362G>A | p.Arg121Gln | p.R121Q | Q9BV73 | protein_coding | tolerated(0.06) | benign(0.034) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
CEP250 | SNV | Missense_Mutation | c.4121C>A | p.Ala1374Asp | p.A1374D | Q9BV73 | protein_coding | deleterious(0.01) | possibly_damaging(0.572) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |